The 2019-nCoV Novel Coronavirus – what we know and what we’re finding out

Dr. Inna Sekirov joined the team of BCCDC PHL Medical Microbiologists in 2017. She is the program head for TB/Mycobacteriology laboratory and has a particular interest in molecular/genomics-based diagnostics and epidemiology. Dr. Natalie Prystajecky is the program head for the Environmental Microbiology program and co-leads the Molecular and Microbial Genomics program at the BCCDC Public Health Laboratory. She is also a clinical assistant professor in the Department of Pathology & Laboratory Medicine at UBC. Dr. Prystajecky’s research expertise includes genomics and molecular diagnostics. She uses emerging technologies to improve routine surveillance and outbreak investigations for pathogens. Dr. Mel Krajden is the medical director of the BCCDC Public Health Laboratory. He is also the medical head of hepatitis at BCCDC and is involved in the BC Hepatitis Testers Cohort. His laboratory research involves the application of molecular techniques to diagnose viruses, assess correlates between infection and clinical disease, use molecular techniques to monitor antiviral efficacy and track microbial infections for epidemiological purposes.

BC CDC Presenters

2/4/2020 8:00:00 PM